[1]
A. Aurbach, W. Russ, J. Brecht, and P. Schädlich, “Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective”, Swiss Med Wkly, vol. 134, no. 2728, pp. 399–405, Jul. 2004.